Vital KSK Holdings, Inc. (JP:3151)
:3151
Top Page
Vital KSK Holdings, Inc.
(3151)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥1,648.00
▲(20.29% Upside)
Action:DowngradedDate:10/30/25
Vital KSK Holdings, Inc. scores well on valuation due to its low P/E ratio and high dividend yield, indicating potential undervaluation. However, technical analysis shows bearish momentum, and financial performance highlights operational and cash flow inefficiencies that need improvement. These factors collectively result in a moderate overall stock score.
Positive Factors
Low leverage / strong equity base
Very low debt-to-equity (0.08) and a 35.36% equity ratio give the company durable financial flexibility. Low leverage reduces refinancing risk, supports capital allocation for operations or M&A, and preserves resilience through industry cycles, aiding multi‑month stability.
Negative Factors
Negative operating and free cash flow
Negative operating and free cash flow, with an OCF to net income ratio of -1.10, indicates the company struggles to convert reported profits into cash. This structural cash generation weakness limits reinvestment, dividend sustainability, and increases reliance on external funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong equity base
Very low debt-to-equity (0.08) and a 35.36% equity ratio give the company durable financial flexibility. Low leverage reduces refinancing risk, supports capital allocation for operations or M&A, and preserves resilience through industry cycles, aiding multi‑month stability.
Read all positive factors
Vital KSK Holdings, Inc. (3151) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥68.17B
Dividend Yield4.22%
Average Volume (3M)121.33K
Price to Earnings (P/E)18.0
Beta (1Y)0.48
Revenue Growth2.23%
EPS Growth72.07%
CountryJP
Employees3,705
SectorHealthcare
Sector Strength45
IndustryMedical - Distribution
Share Statistics
EPS (TTM)19.01
Shares Outstanding51,902,977
10 Day Avg. Volume69,970
30 Day Avg. Volume121,326
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.58
Price to Sales (P/S)0.10
P/FCF Ratio-5.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vital KSK Holdings, Inc. Business Overview & Revenue Model
Company Description
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It a...
How the Company Makes Money
null...
Vital KSK Holdings, Inc. Financial Statement Overview
Summary
Income Statement
76
Positive
Balance Sheet
72
Positive
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 602.28B | 600.37B | 587.48B | 579.77B | 577.25B | 537.06B |
| Gross Profit | 49.38B | 49.22B | 48.30B | 44.96B | 43.98B | 38.22B |
| EBITDA | 10.79B | 14.56B | 12.16B | 11.56B | 10.87B | 5.72B |
| Net Income | 6.96B | 7.31B | 5.84B | 4.83B | 4.77B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 305.27B | 299.43B | 317.26B | 297.32B | 313.03B | 311.40B |
| Cash, Cash Equivalents and Short-Term Investments | 24.39B | 23.10B | 34.71B | 19.03B | 26.97B | 29.78B |
| Total Debt | 6.51B | 7.70B | 10.15B | 10.87B | 12.59B | 17.33B |
| Total Liabilities | 199.57B | 192.12B | 211.31B | 197.15B | 212.99B | 207.48B |
| Stockholders Equity | 104.29B | 105.91B | 104.66B | 98.99B | 98.96B | 102.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -10.59B | 18.47B | -9.60B | 3.35B | -5.23B |
| Operating Cash Flow | 0.00 | -8.02B | 23.57B | -3.00B | 7.49B | -1.39B |
| Investing Cash Flow | 0.00 | 3.52B | -1.82B | -1.04B | -2.01B | 549.00M |
| Financing Cash Flow | 0.00 | -6.54B | -5.77B | -4.08B | -8.49B | -2.52B |
Vital KSK Holdings, Inc. Technical Analysis
Positive
1370.00
Price Trends
1404.95
Positive
1359.25
Positive
1284.70
Positive
Market Momentum
26.77
Negative
66.58
Neutral
83.38
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3151, the sentiment is Positive. The current price of 1370 is below the 20-day moving average (MA) of 1437.52, below the 50-day MA of 1404.95, and above the 200-day MA of 1284.70, indicating a bullish trend. The MACD of 26.77 indicates Negative momentum. The RSI at 66.58 is Neutral, neither overbought nor oversold. The STOCH value of 83.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3151.
Vital KSK Holdings, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥45.39B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
70 Outperform | ¥8.87B | 14.83 | ― | 1.87% | 2.65% | 8.83% | |
67 Neutral | ¥68.17B | 17.99 | ― | 4.22% | 2.23% | 72.07% | |
64 Neutral | ¥12.86B | 10.68 | ― | 3.90% | 3.64% | -4.70% | |
62 Neutral | ¥44.54B | 10.69 | ― | 0.91% | 15.77% | -50.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ¥18.84B | 14.56 | ― | 1.83% | 4.30% | 52.38% |
* Healthcare Sector Average
JP:3151
Vital KSK Holdings, Inc.
1,515.00
363.30
31.54%
JP:2689
OLBA HEALTHCARE HOLDINGS, Inc.
2,113.00
152.53
7.78%
JP:3417
Ohki Health Care Holdings, Inc.
1,366.00
665.89
95.11%
JP:6062
Charm Care Corporation
1,392.00
232.98
20.10%
JP:7071
Amvis Holdings.Inc.
453.00
10.93
2.47%
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC.
3,475.00
781.94
29.04%
Vital KSK Holdings, Inc. Corporate Events
Vital KSK Boosts Shareholder Perks to Reward Long-Term Investors
Feb 26, 2026
Vital KSK Holdings has approved an enhancement to its shareholder benefits program, aiming to make its shares more attractive and to encourage longer-term ownership. The revamped program introduces higher-value QUO card rewards scaled to both shar...
Vital KSK Holdings Lifts Dividend as Nine-Month Profit Slips but Keeps Full-Year Outlook
Feb 10, 2026
Vital KSK Holdings posted consolidated net sales of ¥464.6 billion for the nine months to December 31, 2025, up 0.8% year on year, while core operating profit reached ¥4.0 billion, but ordinary profit fell 42.3% to ¥3.1 billion and ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.